John Ersson is a Stockholm-based Senior Associate working with Roschier’s Private M&A practice, focusing on private M&A and private equity. He joined Roschier in 2017.
John Ersson’s experience includes advising:
- KKR’s life science platform Gamma Biosciences in the USD 215 million sale of Astrea Bioseparations to Biotage;
- Bonnier Ventures in their investment in diagnostics company Elypta;
- Nordstjernan in its investment in audience engagement company Mentimeter.
Stockholm University, LL.M. (2017)